nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—FDPS—Sorafenib—Vismodegib—skin cancer	0.0259	1	CbGdCrCtD
Alendronate—ATP6V1A—hair follicle—skin cancer	0.0248	0.0801	CbGeAlD
Alendronate—PTPRS—connective tissue—skin cancer	0.0206	0.0668	CbGeAlD
Alendronate—FDPS—hair follicle—skin cancer	0.0186	0.0604	CbGeAlD
Alendronate—PTPRE—female reproductive system—skin cancer	0.0179	0.0578	CbGeAlD
Alendronate—PTPN4—female reproductive system—skin cancer	0.017	0.055	CbGeAlD
Alendronate—ATP6V1A—nipple—skin cancer	0.0168	0.0543	CbGeAlD
Alendronate—PTPRE—head—skin cancer	0.0149	0.0483	CbGeAlD
Alendronate—PTPRS—female reproductive system—skin cancer	0.0146	0.0471	CbGeAlD
Alendronate—PTPN4—head—skin cancer	0.0142	0.0459	CbGeAlD
Alendronate—FDPS—nipple—skin cancer	0.0126	0.0409	CbGeAlD
Alendronate—PTPRS—head—skin cancer	0.0122	0.0394	CbGeAlD
Alendronate—ATP6V1A—skin of body—skin cancer	0.0107	0.0348	CbGeAlD
Alendronate—PTPRE—lymph node—skin cancer	0.0104	0.0338	CbGeAlD
Alendronate—PTPN4—lymph node—skin cancer	0.00994	0.0322	CbGeAlD
Alendronate—ATP6V1A—mammalian vulva—skin cancer	0.0098	0.0317	CbGeAlD
Alendronate—FDPS—connective tissue—skin cancer	0.00897	0.029	CbGeAlD
Alendronate—ATP6V1A—lymphoid tissue—skin cancer	0.0087	0.0282	CbGeAlD
Alendronate—PTPRS—lymph node—skin cancer	0.00852	0.0276	CbGeAlD
Alendronate—ATP6V1A—female reproductive system—skin cancer	0.0084	0.0272	CbGeAlD
Alendronate—FDPS—skin of body—skin cancer	0.0081	0.0262	CbGeAlD
Alendronate—Lymphopenia—Temozolomide—skin cancer	0.00795	0.0122	CcSEcCtD
Alendronate—Gastrooesophageal reflux disease—Imiquimod—skin cancer	0.00751	0.0115	CcSEcCtD
Alendronate—Oesophageal ulcer—Docetaxel—skin cancer	0.00741	0.0113	CcSEcCtD
Alendronate—FDPS—mammalian vulva—skin cancer	0.00739	0.0239	CbGeAlD
Alendronate—Ulcer—Imiquimod—skin cancer	0.00717	0.011	CcSEcCtD
Alendronate—ATP6V1A—head—skin cancer	0.00701	0.0227	CbGeAlD
Alendronate—Influenza like illness—Imiquimod—skin cancer	0.00659	0.0101	CcSEcCtD
Alendronate—Photosensitivity—Vemurafenib—skin cancer	0.00658	0.0101	CcSEcCtD
Alendronate—FDPS—lymphoid tissue—skin cancer	0.00656	0.0212	CbGeAlD
Alendronate—FDPS—female reproductive system—skin cancer	0.00632	0.0205	CbGeAlD
Alendronate—Risedronate—PTGS2—skin cancer	0.00605	0.529	CrCbGaD
Alendronate—Alopecia—Vismodegib—skin cancer	0.00572	0.00874	CcSEcCtD
Alendronate—Influenza-like symptoms—Temozolomide—skin cancer	0.00569	0.00871	CcSEcCtD
Alendronate—Duodenal ulcer—Docetaxel—skin cancer	0.0056	0.00856	CcSEcCtD
Alendronate—Dysgeusia—Vismodegib—skin cancer	0.00551	0.00843	CcSEcCtD
Alendronate—Heartburn—Fluorouracil—skin cancer	0.00544	0.00833	CcSEcCtD
Alendronate—Muscle spasms—Vismodegib—skin cancer	0.00541	0.00828	CcSEcCtD
Alendronate—Clodronate—PTGS2—skin cancer	0.00539	0.471	CrCbGaD
Alendronate—Dry skin—Vemurafenib—skin cancer	0.00529	0.0081	CcSEcCtD
Alendronate—Lymphopenia—Docetaxel—skin cancer	0.00528	0.00808	CcSEcCtD
Alendronate—FDPS—head—skin cancer	0.00528	0.0171	CbGeAlD
Alendronate—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.0052	0.00796	CcSEcCtD
Alendronate—Ulcer—Bleomycin—skin cancer	0.0051	0.0078	CcSEcCtD
Alendronate—ATP6V1A—lymph node—skin cancer	0.00491	0.0159	CbGeAlD
Alendronate—Hypocalcaemia—Dactinomycin—skin cancer	0.00491	0.00751	CcSEcCtD
Alendronate—Myalgia—Vismodegib—skin cancer	0.00479	0.00733	CcSEcCtD
Alendronate—Ulcer—Dactinomycin—skin cancer	0.00475	0.00727	CcSEcCtD
Alendronate—Photosensitivity reaction—Vemurafenib—skin cancer	0.00456	0.00697	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00441	0.00675	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00419	0.0064	CcSEcCtD
Alendronate—Musculoskeletal pain—Temozolomide—skin cancer	0.00412	0.0063	CcSEcCtD
Alendronate—Oesophagitis—Dactinomycin—skin cancer	0.00411	0.00628	CcSEcCtD
Alendronate—Dyspepsia—Vismodegib—skin cancer	0.00404	0.00619	CcSEcCtD
Alendronate—Ulcer—Fluorouracil—skin cancer	0.00396	0.00606	CcSEcCtD
Alendronate—Influenza like illness—Temozolomide—skin cancer	0.00395	0.00604	CcSEcCtD
Alendronate—Oedema peripheral—Vemurafenib—skin cancer	0.00394	0.00602	CcSEcCtD
Alendronate—Heartburn—Docetaxel—skin cancer	0.00393	0.00601	CcSEcCtD
Alendronate—Constipation—Vismodegib—skin cancer	0.00393	0.00601	CcSEcCtD
Alendronate—Pain—Vismodegib—skin cancer	0.00393	0.00601	CcSEcCtD
Alendronate—Photosensitivity reaction—Imiquimod—skin cancer	0.00389	0.00594	CcSEcCtD
Alendronate—Erythema multiforme—Vemurafenib—skin cancer	0.00378	0.00578	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00376	0.00576	CcSEcCtD
Alendronate—Gastrointestinal pain—Vismodegib—skin cancer	0.00376	0.00575	CcSEcCtD
Alendronate—FDPS—lymph node—skin cancer	0.0037	0.012	CbGeAlD
Alendronate—Abdominal pain—Vismodegib—skin cancer	0.00363	0.00556	CcSEcCtD
Alendronate—Alopecia—Vemurafenib—skin cancer	0.00353	0.0054	CcSEcCtD
Alendronate—Erythema—Vemurafenib—skin cancer	0.00348	0.00532	CcSEcCtD
Alendronate—Haemoglobin—Imiquimod—skin cancer	0.00342	0.00524	CcSEcCtD
Alendronate—Oesophagitis—Fluorouracil—skin cancer	0.00342	0.00524	CcSEcCtD
Alendronate—Haemorrhage—Imiquimod—skin cancer	0.00341	0.00521	CcSEcCtD
Alendronate—Dysgeusia—Vemurafenib—skin cancer	0.00341	0.00521	CcSEcCtD
Alendronate—Asthenia—Vismodegib—skin cancer	0.0033	0.00504	CcSEcCtD
Alendronate—Pruritus—Vismodegib—skin cancer	0.00325	0.00497	CcSEcCtD
Alendronate—Erythema multiforme—Imiquimod—skin cancer	0.00322	0.00493	CcSEcCtD
Alendronate—Diarrhoea—Vismodegib—skin cancer	0.00314	0.00481	CcSEcCtD
Alendronate—Photosensitivity—Fluorouracil—skin cancer	0.0031	0.00474	CcSEcCtD
Alendronate—Alopecia—Imiquimod—skin cancer	0.00301	0.00461	CcSEcCtD
Alendronate—Erythema—Imiquimod—skin cancer	0.00297	0.00454	CcSEcCtD
Alendronate—Myalgia—Vemurafenib—skin cancer	0.00296	0.00453	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00294	0.0045	CcSEcCtD
Alendronate—Vomiting—Vismodegib—skin cancer	0.00292	0.00447	CcSEcCtD
Alendronate—Drug interaction—Docetaxel—skin cancer	0.00292	0.00446	CcSEcCtD
Alendronate—Rash—Vismodegib—skin cancer	0.0029	0.00443	CcSEcCtD
Alendronate—Dermatitis—Vismodegib—skin cancer	0.00289	0.00443	CcSEcCtD
Alendronate—Dysphagia—Dactinomycin—skin cancer	0.00282	0.00431	CcSEcCtD
Alendronate—Infection—Vemurafenib—skin cancer	0.00282	0.00431	CcSEcCtD
Alendronate—Ill-defined disorder—Imiquimod—skin cancer	0.00275	0.00421	CcSEcCtD
Alendronate—Nausea—Vismodegib—skin cancer	0.00273	0.00418	CcSEcCtD
Alendronate—Angioedema—Imiquimod—skin cancer	0.00271	0.00415	CcSEcCtD
Alendronate—Dry skin—Temozolomide—skin cancer	0.00271	0.00414	CcSEcCtD
Alendronate—Malaise—Imiquimod—skin cancer	0.00268	0.00409	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00266	0.00407	CcSEcCtD
Alendronate—Stomatitis—Bleomycin—skin cancer	0.00263	0.00402	CcSEcCtD
Alendronate—Influenza like illness—Docetaxel—skin cancer	0.00263	0.00402	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00259	0.00396	CcSEcCtD
Alendronate—Abdominal distension—Temozolomide—skin cancer	0.00257	0.00393	CcSEcCtD
Alendronate—Dysphagia—Temozolomide—skin cancer	0.00255	0.0039	CcSEcCtD
Alendronate—Chest pain—Imiquimod—skin cancer	0.00253	0.00386	CcSEcCtD
Alendronate—Myalgia—Imiquimod—skin cancer	0.00253	0.00386	CcSEcCtD
Alendronate—Discomfort—Imiquimod—skin cancer	0.0025	0.00382	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00249	0.00381	CcSEcCtD
Alendronate—Dry skin—Fluorouracil—skin cancer	0.00249	0.00381	CcSEcCtD
Alendronate—Oesophagitis—Docetaxel—skin cancer	0.00247	0.00378	CcSEcCtD
Alendronate—Stomatitis—Dactinomycin—skin cancer	0.00245	0.00375	CcSEcCtD
Alendronate—Haemoglobin—Bleomycin—skin cancer	0.00243	0.00372	CcSEcCtD
Alendronate—Constipation—Vemurafenib—skin cancer	0.00243	0.00371	CcSEcCtD
Alendronate—Haemorrhage—Bleomycin—skin cancer	0.00242	0.0037	CcSEcCtD
Alendronate—Infection—Imiquimod—skin cancer	0.00241	0.00368	CcSEcCtD
Alendronate—Dysphagia—Fluorouracil—skin cancer	0.00235	0.0036	CcSEcCtD
Alendronate—Photosensitivity reaction—Temozolomide—skin cancer	0.00233	0.00356	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00226	0.00345	CcSEcCtD
Alendronate—Body temperature increased—Vemurafenib—skin cancer	0.00224	0.00343	CcSEcCtD
Alendronate—Stomatitis—Temozolomide—skin cancer	0.00222	0.00339	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00221	0.00337	CcSEcCtD
Alendronate—Photosensitivity reaction—Fluorouracil—skin cancer	0.00215	0.00328	CcSEcCtD
Alendronate—Alopecia—Bleomycin—skin cancer	0.00214	0.00327	CcSEcCtD
Alendronate—Erythema multiforme—Dactinomycin—skin cancer	0.00213	0.00327	CcSEcCtD
Alendronate—Dyspepsia—Imiquimod—skin cancer	0.00213	0.00326	CcSEcCtD
Alendronate—Erythema—Bleomycin—skin cancer	0.00211	0.00322	CcSEcCtD
Alendronate—Hypersensitivity—Vemurafenib—skin cancer	0.00209	0.0032	CcSEcCtD
Alendronate—Pain—Imiquimod—skin cancer	0.00207	0.00317	CcSEcCtD
Alendronate—Haemoglobin—Temozolomide—skin cancer	0.00205	0.00314	CcSEcCtD
Alendronate—Stomatitis—Fluorouracil—skin cancer	0.00204	0.00313	CcSEcCtD
Alendronate—Haemorrhage—Temozolomide—skin cancer	0.00204	0.00312	CcSEcCtD
Alendronate—Asthenia—Vemurafenib—skin cancer	0.00204	0.00312	CcSEcCtD
Alendronate—Oedema peripheral—Temozolomide—skin cancer	0.00201	0.00308	CcSEcCtD
Alendronate—Pruritus—Vemurafenib—skin cancer	0.00201	0.00307	CcSEcCtD
Alendronate—Alopecia—Dactinomycin—skin cancer	0.002	0.00305	CcSEcCtD
Alendronate—Feeling abnormal—Imiquimod—skin cancer	0.002	0.00305	CcSEcCtD
Alendronate—Gastrointestinal pain—Imiquimod—skin cancer	0.00198	0.00303	CcSEcCtD
Alendronate—Erythema—Dactinomycin—skin cancer	0.00197	0.00301	CcSEcCtD
Alendronate—Ill-defined disorder—Bleomycin—skin cancer	0.00196	0.00299	CcSEcCtD
Alendronate—Anaemia—Bleomycin—skin cancer	0.00195	0.00298	CcSEcCtD
Alendronate—Diarrhoea—Vemurafenib—skin cancer	0.00194	0.00297	CcSEcCtD
Alendronate—Erythema multiforme—Temozolomide—skin cancer	0.00193	0.00295	CcSEcCtD
Alendronate—Urticaria—Imiquimod—skin cancer	0.00192	0.00294	CcSEcCtD
Alendronate—Abdominal pain—Imiquimod—skin cancer	0.00191	0.00293	CcSEcCtD
Alendronate—Body temperature increased—Imiquimod—skin cancer	0.00191	0.00293	CcSEcCtD
Alendronate—Malaise—Bleomycin—skin cancer	0.0019	0.00291	CcSEcCtD
Alendronate—Haemoglobin—Fluorouracil—skin cancer	0.00189	0.00289	CcSEcCtD
Alendronate—Haemorrhage—Fluorouracil—skin cancer	0.00188	0.00288	CcSEcCtD
Alendronate—Dizziness—Vemurafenib—skin cancer	0.00188	0.00287	CcSEcCtD
Alendronate—Ill-defined disorder—Dactinomycin—skin cancer	0.00182	0.00279	CcSEcCtD
Alendronate—Anaemia—Dactinomycin—skin cancer	0.00182	0.00278	CcSEcCtD
Alendronate—Vomiting—Vemurafenib—skin cancer	0.0018	0.00276	CcSEcCtD
Alendronate—Alopecia—Temozolomide—skin cancer	0.0018	0.00276	CcSEcCtD
Alendronate—Dry skin—Docetaxel—skin cancer	0.0018	0.00275	CcSEcCtD
Alendronate—Chest pain—Bleomycin—skin cancer	0.00179	0.00274	CcSEcCtD
Alendronate—Myalgia—Bleomycin—skin cancer	0.00179	0.00274	CcSEcCtD
Alendronate—Rash—Vemurafenib—skin cancer	0.00179	0.00274	CcSEcCtD
Alendronate—Dermatitis—Vemurafenib—skin cancer	0.00179	0.00274	CcSEcCtD
Alendronate—Hypersensitivity—Imiquimod—skin cancer	0.00178	0.00273	CcSEcCtD
Alendronate—Headache—Vemurafenib—skin cancer	0.00178	0.00272	CcSEcCtD
Alendronate—Erythema—Temozolomide—skin cancer	0.00178	0.00272	CcSEcCtD
Alendronate—Discomfort—Bleomycin—skin cancer	0.00177	0.00271	CcSEcCtD
Alendronate—Malaise—Dactinomycin—skin cancer	0.00177	0.00271	CcSEcCtD
Alendronate—Cramp muscle—Docetaxel—skin cancer	0.00177	0.0027	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00177	0.0027	CcSEcCtD
Alendronate—Dysgeusia—Temozolomide—skin cancer	0.00174	0.00266	CcSEcCtD
Alendronate—Asthenia—Imiquimod—skin cancer	0.00174	0.00266	CcSEcCtD
Alendronate—Pruritus—Imiquimod—skin cancer	0.00171	0.00262	CcSEcCtD
Alendronate—Infection—Bleomycin—skin cancer	0.00171	0.00261	CcSEcCtD
Alendronate—Dysphagia—Docetaxel—skin cancer	0.0017	0.0026	CcSEcCtD
Alendronate—Nausea—Vemurafenib—skin cancer	0.00169	0.00258	CcSEcCtD
Alendronate—Myalgia—Dactinomycin—skin cancer	0.00167	0.00256	CcSEcCtD
Alendronate—Alopecia—Fluorouracil—skin cancer	0.00166	0.00254	CcSEcCtD
Alendronate—Diarrhoea—Imiquimod—skin cancer	0.00166	0.00253	CcSEcCtD
Alendronate—Discomfort—Dactinomycin—skin cancer	0.00165	0.00253	CcSEcCtD
Alendronate—Ill-defined disorder—Temozolomide—skin cancer	0.00165	0.00252	CcSEcCtD
Alendronate—Anaemia—Temozolomide—skin cancer	0.00164	0.00251	CcSEcCtD
Alendronate—Erythema—Fluorouracil—skin cancer	0.00164	0.00251	CcSEcCtD
Alendronate—Angioedema—Temozolomide—skin cancer	0.00162	0.00248	CcSEcCtD
Alendronate—Malaise—Temozolomide—skin cancer	0.0016	0.00245	CcSEcCtD
Alendronate—Dizziness—Imiquimod—skin cancer	0.0016	0.00245	CcSEcCtD
Alendronate—Vertigo—Temozolomide—skin cancer	0.0016	0.00244	CcSEcCtD
Alendronate—Infection—Dactinomycin—skin cancer	0.00159	0.00244	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00157	0.0024	CcSEcCtD
Alendronate—Vomiting—Imiquimod—skin cancer	0.00154	0.00235	CcSEcCtD
Alendronate—Rash—Imiquimod—skin cancer	0.00153	0.00234	CcSEcCtD
Alendronate—Dermatitis—Imiquimod—skin cancer	0.00153	0.00233	CcSEcCtD
Alendronate—Headache—Imiquimod—skin cancer	0.00152	0.00232	CcSEcCtD
Alendronate—Anaemia—Fluorouracil—skin cancer	0.00151	0.00232	CcSEcCtD
Alendronate—Myalgia—Temozolomide—skin cancer	0.00151	0.00232	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.0015	0.00229	CcSEcCtD
Alendronate—Discomfort—Temozolomide—skin cancer	0.0015	0.00229	CcSEcCtD
Alendronate—Stomatitis—Docetaxel—skin cancer	0.00147	0.00226	CcSEcCtD
Alendronate—Pain—Bleomycin—skin cancer	0.00147	0.00225	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00146	0.00224	CcSEcCtD
Alendronate—Infection—Temozolomide—skin cancer	0.00144	0.0022	CcSEcCtD
Alendronate—Nausea—Imiquimod—skin cancer	0.00144	0.0022	CcSEcCtD
Alendronate—Feeling abnormal—Bleomycin—skin cancer	0.00142	0.00217	CcSEcCtD
Alendronate—Myalgia—Fluorouracil—skin cancer	0.00139	0.00213	CcSEcCtD
Alendronate—Chest pain—Fluorouracil—skin cancer	0.00139	0.00213	CcSEcCtD
Alendronate—Discomfort—Fluorouracil—skin cancer	0.00138	0.00211	CcSEcCtD
Alendronate—Pain—Dactinomycin—skin cancer	0.00137	0.0021	CcSEcCtD
Alendronate—Urticaria—Bleomycin—skin cancer	0.00137	0.00209	CcSEcCtD
Alendronate—Haemoglobin—Docetaxel—skin cancer	0.00136	0.00209	CcSEcCtD
Alendronate—Body temperature increased—Bleomycin—skin cancer	0.00136	0.00208	CcSEcCtD
Alendronate—Haemorrhage—Docetaxel—skin cancer	0.00136	0.00208	CcSEcCtD
Alendronate—Oedema peripheral—Docetaxel—skin cancer	0.00134	0.00205	CcSEcCtD
Alendronate—Infection—Fluorouracil—skin cancer	0.00133	0.00203	CcSEcCtD
Alendronate—Feeling abnormal—Dactinomycin—skin cancer	0.00132	0.00202	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00132	0.00202	CcSEcCtD
Alendronate—Gastrointestinal pain—Dactinomycin—skin cancer	0.00131	0.00201	CcSEcCtD
Alendronate—Erythema multiforme—Docetaxel—skin cancer	0.00128	0.00196	CcSEcCtD
Alendronate—Dyspepsia—Temozolomide—skin cancer	0.00128	0.00195	CcSEcCtD
Alendronate—Abdominal pain—Dactinomycin—skin cancer	0.00127	0.00194	CcSEcCtD
Alendronate—Body temperature increased—Dactinomycin—skin cancer	0.00127	0.00194	CcSEcCtD
Alendronate—Hypersensitivity—Bleomycin—skin cancer	0.00127	0.00194	CcSEcCtD
Alendronate—Constipation—Temozolomide—skin cancer	0.00124	0.0019	CcSEcCtD
Alendronate—Pain—Temozolomide—skin cancer	0.00124	0.0019	CcSEcCtD
Alendronate—Asthenia—Bleomycin—skin cancer	0.00123	0.00189	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00122	0.00186	CcSEcCtD
Alendronate—Pruritus—Bleomycin—skin cancer	0.00122	0.00186	CcSEcCtD
Alendronate—Alopecia—Docetaxel—skin cancer	0.0012	0.00184	CcSEcCtD
Alendronate—Feeling abnormal—Temozolomide—skin cancer	0.0012	0.00183	CcSEcCtD
Alendronate—Gastrointestinal pain—Temozolomide—skin cancer	0.00119	0.00181	CcSEcCtD
Alendronate—Erythema—Docetaxel—skin cancer	0.00118	0.00181	CcSEcCtD
Alendronate—Hypersensitivity—Dactinomycin—skin cancer	0.00118	0.00181	CcSEcCtD
Alendronate—Dyspepsia—Fluorouracil—skin cancer	0.00118	0.0018	CcSEcCtD
Alendronate—Dysgeusia—Docetaxel—skin cancer	0.00116	0.00177	CcSEcCtD
Alendronate—Urticaria—Temozolomide—skin cancer	0.00115	0.00176	CcSEcCtD
Alendronate—Asthenia—Dactinomycin—skin cancer	0.00115	0.00176	CcSEcCtD
Alendronate—Body temperature increased—Temozolomide—skin cancer	0.00115	0.00175	CcSEcCtD
Alendronate—Abdominal pain—Temozolomide—skin cancer	0.00115	0.00175	CcSEcCtD
Alendronate—Pain—Fluorouracil—skin cancer	0.00114	0.00175	CcSEcCtD
Alendronate—Muscle spasms—Docetaxel—skin cancer	0.00114	0.00174	CcSEcCtD
Alendronate—Feeling abnormal—Fluorouracil—skin cancer	0.0011	0.00169	CcSEcCtD
Alendronate—Diarrhoea—Dactinomycin—skin cancer	0.0011	0.00168	CcSEcCtD
Alendronate—Vomiting—Bleomycin—skin cancer	0.00109	0.00167	CcSEcCtD
Alendronate—Anaemia—Docetaxel—skin cancer	0.00109	0.00167	CcSEcCtD
Alendronate—Rash—Bleomycin—skin cancer	0.00108	0.00166	CcSEcCtD
Alendronate—Dermatitis—Bleomycin—skin cancer	0.00108	0.00166	CcSEcCtD
Alendronate—Hypersensitivity—Temozolomide—skin cancer	0.00107	0.00164	CcSEcCtD
Alendronate—Urticaria—Fluorouracil—skin cancer	0.00106	0.00162	CcSEcCtD
Alendronate—Body temperature increased—Fluorouracil—skin cancer	0.00106	0.00162	CcSEcCtD
Alendronate—Asthenia—Temozolomide—skin cancer	0.00104	0.00159	CcSEcCtD
Alendronate—Pruritus—Temozolomide—skin cancer	0.00103	0.00157	CcSEcCtD
Alendronate—Nausea—Bleomycin—skin cancer	0.00102	0.00156	CcSEcCtD
Alendronate—Vomiting—Dactinomycin—skin cancer	0.00102	0.00156	CcSEcCtD
Alendronate—Rash—Dactinomycin—skin cancer	0.00101	0.00155	CcSEcCtD
Alendronate—Chest pain—Docetaxel—skin cancer	0.00101	0.00154	CcSEcCtD
Alendronate—Myalgia—Docetaxel—skin cancer	0.00101	0.00154	CcSEcCtD
Alendronate—Diarrhoea—Temozolomide—skin cancer	0.000993	0.00152	CcSEcCtD
Alendronate—Hypersensitivity—Fluorouracil—skin cancer	0.000985	0.00151	CcSEcCtD
Alendronate—Dizziness—Temozolomide—skin cancer	0.000959	0.00147	CcSEcCtD
Alendronate—Infection—Docetaxel—skin cancer	0.000959	0.00147	CcSEcCtD
Alendronate—Nausea—Dactinomycin—skin cancer	0.000953	0.00146	CcSEcCtD
Alendronate—Pruritus—Fluorouracil—skin cancer	0.000946	0.00145	CcSEcCtD
Alendronate—Vomiting—Temozolomide—skin cancer	0.000922	0.00141	CcSEcCtD
Alendronate—Rash—Temozolomide—skin cancer	0.000915	0.0014	CcSEcCtD
Alendronate—Diarrhoea—Fluorouracil—skin cancer	0.000915	0.0014	CcSEcCtD
Alendronate—Dermatitis—Temozolomide—skin cancer	0.000914	0.0014	CcSEcCtD
Alendronate—Headache—Temozolomide—skin cancer	0.000909	0.00139	CcSEcCtD
Alendronate—Dizziness—Fluorouracil—skin cancer	0.000884	0.00135	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000879	0.00134	CcSEcCtD
Alendronate—Nausea—Temozolomide—skin cancer	0.000862	0.00132	CcSEcCtD
Alendronate—Vomiting—Fluorouracil—skin cancer	0.00085	0.0013	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—skin cancer	0.000849	0.0013	CcSEcCtD
Alendronate—Rash—Fluorouracil—skin cancer	0.000843	0.00129	CcSEcCtD
Alendronate—Dermatitis—Fluorouracil—skin cancer	0.000842	0.00129	CcSEcCtD
Alendronate—Headache—Fluorouracil—skin cancer	0.000837	0.00128	CcSEcCtD
Alendronate—Pain—Docetaxel—skin cancer	0.000825	0.00126	CcSEcCtD
Alendronate—Constipation—Docetaxel—skin cancer	0.000825	0.00126	CcSEcCtD
Alendronate—Feeling abnormal—Docetaxel—skin cancer	0.000795	0.00122	CcSEcCtD
Alendronate—Nausea—Fluorouracil—skin cancer	0.000794	0.00121	CcSEcCtD
Alendronate—Gastrointestinal pain—Docetaxel—skin cancer	0.000789	0.00121	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—skin cancer	0.000763	0.00117	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—skin cancer	0.000763	0.00117	CcSEcCtD
Alendronate—Hypersensitivity—Docetaxel—skin cancer	0.000711	0.00109	CcSEcCtD
Alendronate—Asthenia—Docetaxel—skin cancer	0.000692	0.00106	CcSEcCtD
Alendronate—Pruritus—Docetaxel—skin cancer	0.000683	0.00104	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—skin cancer	0.00066	0.00101	CcSEcCtD
Alendronate—Dizziness—Docetaxel—skin cancer	0.000638	0.000976	CcSEcCtD
Alendronate—Vomiting—Docetaxel—skin cancer	0.000613	0.000938	CcSEcCtD
Alendronate—Rash—Docetaxel—skin cancer	0.000608	0.000931	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—skin cancer	0.000608	0.00093	CcSEcCtD
Alendronate—Headache—Docetaxel—skin cancer	0.000604	0.000925	CcSEcCtD
Alendronate—Nausea—Docetaxel—skin cancer	0.000573	0.000877	CcSEcCtD
